Chronic inflammation is a well-recognized tumor-enabling capability, which allows nascent
tumors to escape immunosurveillance. A number of soluble and cellular inflammatory …

Chronic inflammation is a well-known tumor-enabling capacity, which allows nascent tumors
to acquire all the hallmark capabilities, including the escape from immunosurveillance …

Background Active surveillance (AS) is one of the treatment alternatives in low‐risk prostate
cancer (PCa). The pathological upgrading after radical prostatectomy (RP) were …

Prostate intratumoral heterogeneity, driven by epithelial–mesenchymal plasticity, contributes
to the limited treatment response, and it is therefore necessary to use the biomarkers to …

Background The neutrophil-lymphocyte ratio (NLR) is an inexpensive and accessible
prognostic marker for many cancers, including metastatic castration-resistant prostate …

Purpose To investigate the role of inflammatory factors including systemic immune-
inflammation index (SII) and neutrophil to lymphocyte ratio (NLR) in predicting Gleason …

Widespread prostate-specific antigen (PSA) testing notably increased the number of
prostate cancer (PCa) diagnoses. However, about 30% of these patients have low-risk …

Objective To predict prostate cancer using novel biomarker ratios and create a predictive
scoring system. Materials and methods Data of a total of 703 patients who consulted Urology …

Objective: To examine the predictive value of neutrophil-to-lymphocyte ratio in localized
prostate cancer for surgical pathology and recurrence in patients treated by radical …

Backgrounds The association of neutrophil-lymphocyte ratio (NLR) and CD34 expression
level with PSA level, Gleason score, and clinical stage was investigated in patients with …